Skip to main content
Erschienen in: World Journal of Surgery 7/2019

27.02.2019 | Original Scientific Report

Effect of High Postoperative Body Temperature on Long-Term Prognosis in Patients with Gastric Cancer After Radical Resection

verfasst von: Hua-Long Zheng, Jun Lu, Ping Li, Jian-Wei Xie, Jia-Bin Wang, Jian-Xian Lin, Qi-Yue Chen, Long-Long Cao, Mi Lin, Ru-Hong Tu, Ze-Ning Huang, Ju-Li Lin, Chao-Hui Zheng, Chang-Ming Huang

Erschienen in: World Journal of Surgery | Ausgabe 7/2019

Einloggen, um Zugang zu erhalten

Abstract

Background

There is a lack of data on the effect of high postoperative body temperature on disease-free survival (DFS) in patients who underwent radical gastrectomy.

Methods

Patients who underwent radical gastrectomy from January 2006 to December 2011 were selected. The highest body temperature within 1 week after operation was used to establish diagnostic thresholds for high and low body temperature through X-tile software.

Results

A total of 1396 patients were included in the analysis. The diagnostic threshold for high body temperature was defined as 38 °C; 370 patients were allocated to the high-temperature group (HTG), while another 1026 patients were allocated to the low-temperature group (LTG). For all patients, survival analysis showed that 5-year DFS in the HTG was significantly lower than that for the LTG (55.6% vs 63.9%, P = 0.007). Multivariate analysis revealed that high postoperative body temperature was an independent prognostic risk factor for 5-year DFS (HR = 1.288 (1.067–1.555), P = 0.008). For patients without complications, survival analysis showed that the 5-year DFS rate in the HTG was lower than that for the LTG (57.5% vs 64.4%, P = 0.051), especially in patients with stage III gastric cancer (31.3% vs 41.7%, P = 0.037). For patients with complications or infectious complications, there were no significant differences between the HTG and LTG regarding 5-year DFS (49.3% vs 58.2%, P = 0.23 and 49.4% vs 55.1%, P = 0.481, respectively).

Conclusion

For stage III gastric cancer patients without complications, high postoperative body temperature can significantly reduce the 5-year DFS. These patients may benefit from more aggressive adjuvant therapy and postoperative surveillance regimens.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Jemal A, Bray F, Center MM et al (2011) Global cancer statistics. CA Cancer J Clin 61:69–90CrossRefPubMed Jemal A, Bray F, Center MM et al (2011) Global cancer statistics. CA Cancer J Clin 61:69–90CrossRefPubMed
2.
Zurück zum Zitat Kamangar F, Dores GM, Anderson WF (2006) Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world. J Clin Oncol 24:2137–2150CrossRefPubMed Kamangar F, Dores GM, Anderson WF (2006) Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world. J Clin Oncol 24:2137–2150CrossRefPubMed
3.
Zurück zum Zitat Maruyama K, Kaminishi M, Hayashi K, Isobe Y, Honda I, Katai H et al (2006) Gastric cancer treated in 1991 in Japan: data analysis of nationwide registry. Gastric Cancer 9:51–66CrossRefPubMed Maruyama K, Kaminishi M, Hayashi K, Isobe Y, Honda I, Katai H et al (2006) Gastric cancer treated in 1991 in Japan: data analysis of nationwide registry. Gastric Cancer 9:51–66CrossRefPubMed
4.
Zurück zum Zitat Isobe Y, Nashimoto A, Akazawa K, Oda I, Hayashi K, Miyashiro I et al (2011) Gastric cancer treatment in Japan: 2008 annual report of the JGCA nationwide registry. Gastric Cancer 14:301–316CrossRefPubMedPubMedCentral Isobe Y, Nashimoto A, Akazawa K, Oda I, Hayashi K, Miyashiro I et al (2011) Gastric cancer treatment in Japan: 2008 annual report of the JGCA nationwide registry. Gastric Cancer 14:301–316CrossRefPubMedPubMedCentral
5.
Zurück zum Zitat Maehara Y, Hasuda S, Koga T, Tokunaga E, Kakeji Y, Sugimachi K (2000) Postoperative outcome and sites of recurrence in patients following curative resection of gastric cancer. Br J Surg 87:353–357CrossRefPubMed Maehara Y, Hasuda S, Koga T, Tokunaga E, Kakeji Y, Sugimachi K (2000) Postoperative outcome and sites of recurrence in patients following curative resection of gastric cancer. Br J Surg 87:353–357CrossRefPubMed
6.
Zurück zum Zitat Shiraishi N, Inomata M, Osawa N, Yasuda K, Adachi Y, Kitano S (2000) Early and late recurrence after gastrectomy for gastric carcinoma. Univariate and multivariate analyses. Cancer 89:255–261CrossRefPubMed Shiraishi N, Inomata M, Osawa N, Yasuda K, Adachi Y, Kitano S (2000) Early and late recurrence after gastrectomy for gastric carcinoma. Univariate and multivariate analyses. Cancer 89:255–261CrossRefPubMed
7.
Zurück zum Zitat Adachi Y, Oshiro T, Mori M, Maehara Y, Sugimachi M (1996) Prediction of early and late recurrence after curative resection for gastric carcinoma. Cancer 77:2445–2448CrossRefPubMed Adachi Y, Oshiro T, Mori M, Maehara Y, Sugimachi M (1996) Prediction of early and late recurrence after curative resection for gastric carcinoma. Cancer 77:2445–2448CrossRefPubMed
8.
Zurück zum Zitat Maruyama K (1987) The most important prognostic factors for gastric cancer patients. Scand J Gastroenterol 22:63–68CrossRef Maruyama K (1987) The most important prognostic factors for gastric cancer patients. Scand J Gastroenterol 22:63–68CrossRef
9.
Zurück zum Zitat Sierzega M, Kolodziejczyk P, Kulig J (2010) Impact of anastomotic leakage on long-term survival after total gastrectomy for carcinoma of the stomach. Br J Surg 97:1035–1042CrossRefPubMed Sierzega M, Kolodziejczyk P, Kulig J (2010) Impact of anastomotic leakage on long-term survival after total gastrectomy for carcinoma of the stomach. Br J Surg 97:1035–1042CrossRefPubMed
10.
Zurück zum Zitat Tokunaga M et al (2013) Poor survival rate in patients with postoperative intra-abdominal infectious complications following curative gastrectomy for gastric cancer. Ann Surg Oncol 20(5):1575–1583CrossRefPubMed Tokunaga M et al (2013) Poor survival rate in patients with postoperative intra-abdominal infectious complications following curative gastrectomy for gastric cancer. Ann Surg Oncol 20(5):1575–1583CrossRefPubMed
11.
Zurück zum Zitat Walker KG, Bell SW, Rickard MJ, Mehanna D, Dent OF, Chapuis PH et al (2004) Anastomotic leakage is predictive of diminished survival after potentially curative resection for colorectal cancer. Ann Surg 240:255–259CrossRefPubMedPubMedCentral Walker KG, Bell SW, Rickard MJ, Mehanna D, Dent OF, Chapuis PH et al (2004) Anastomotic leakage is predictive of diminished survival after potentially curative resection for colorectal cancer. Ann Surg 240:255–259CrossRefPubMedPubMedCentral
12.
Zurück zum Zitat Hirai T, Yamashita Y, Mukaida H, Kuwahara M, Inoue H, Toge T (1998) Poor prognosis in esophageal cancer patients with postoperative complications. Surg Today 28:576–579CrossRefPubMed Hirai T, Yamashita Y, Mukaida H, Kuwahara M, Inoue H, Toge T (1998) Poor prognosis in esophageal cancer patients with postoperative complications. Surg Today 28:576–579CrossRefPubMed
13.
Zurück zum Zitat Rizk NP, Bach PB, Schrag D, Bains MS, Turnbull AD, Karpeh M et al (2004) The impact of complications on outcomes after resection for esophageal and gastroesophageal junction carcinoma. J Am Coll Surg 198:42–50CrossRefPubMed Rizk NP, Bach PB, Schrag D, Bains MS, Turnbull AD, Karpeh M et al (2004) The impact of complications on outcomes after resection for esophageal and gastroesophageal junction carcinoma. J Am Coll Surg 198:42–50CrossRefPubMed
14.
Zurück zum Zitat Artinyan A et al (2015) Infectious postoperative complications decrease long-term survival in patients undergoing curative surgery for colorectal cancer. Ann Surg 261(3):497–505CrossRefPubMed Artinyan A et al (2015) Infectious postoperative complications decrease long-term survival in patients undergoing curative surgery for colorectal cancer. Ann Surg 261(3):497–505CrossRefPubMed
16.
Zurück zum Zitat Swisher ED, Kahleifeh B, Pohl JF (1997) Blood cultures in febrile patients after hysterectomy. Cost-effectiveness. J Reprod Med 42(9):547–550PubMed Swisher ED, Kahleifeh B, Pohl JF (1997) Blood cultures in febrile patients after hysterectomy. Cost-effectiveness. J Reprod Med 42(9):547–550PubMed
17.
Zurück zum Zitat De la Torre SH, Mandel L, Goff BA (2003) Evaluation of postoperative fever: usefulness and cost-effectiveness of routine workup. Am J Obstet Gynecol 188(6):1642–1647CrossRefPubMed De la Torre SH, Mandel L, Goff BA (2003) Evaluation of postoperative fever: usefulness and cost-effectiveness of routine workup. Am J Obstet Gynecol 188(6):1642–1647CrossRefPubMed
18.
Zurück zum Zitat Garibaldi RA et al (1985) Evidence for the non-infectious etiology of early postoperative fever. Infect Control 6(7):273–277CrossRefPubMed Garibaldi RA et al (1985) Evidence for the non-infectious etiology of early postoperative fever. Infect Control 6(7):273–277CrossRefPubMed
19.
Zurück zum Zitat Wortel CH et al (1993) Interleukin-6 mediates host defense responses induced by abdominal surgery. Surgery 114(3):564–570PubMed Wortel CH et al (1993) Interleukin-6 mediates host defense responses induced by abdominal surgery. Surgery 114(3):564–570PubMed
20.
Zurück zum Zitat Badillo AT, Sarani B, Evans SR (2002) Optimizing the use of blood cultures in the febrile postoperative patient. J Am Coll Surg 194(4):477–487CrossRefPubMed Badillo AT, Sarani B, Evans SR (2002) Optimizing the use of blood cultures in the febrile postoperative patient. J Am Coll Surg 194(4):477–487CrossRefPubMed
21.
Zurück zum Zitat Japanese Gastric Cancer Association (2011) Japanese gastric cancer treatment guidelines 2010 (ver. 3). Gastric Cancer 2:113–123CrossRef Japanese Gastric Cancer Association (2011) Japanese gastric cancer treatment guidelines 2010 (ver. 3). Gastric Cancer 2:113–123CrossRef
22.
Zurück zum Zitat Biondi A, Hyung WJ, Hyung WJ (2011) Seventh edition of TNM classification for gastric cancer. J Clin Oncol 29:4338–4339CrossRefPubMed Biondi A, Hyung WJ, Hyung WJ (2011) Seventh edition of TNM classification for gastric cancer. J Clin Oncol 29:4338–4339CrossRefPubMed
23.
Zurück zum Zitat Wente MN, Veit JA, Bassi C, Dervenis C, Fingerhut A, Gouma DJ et al (2007) Postpancreatectomy hemorrhage (PPH): an International Study Group of Pancreatic Surgery (ISGPS) definition. Surgery 142:20–25CrossRefPubMed Wente MN, Veit JA, Bassi C, Dervenis C, Fingerhut A, Gouma DJ et al (2007) Postpancreatectomy hemorrhage (PPH): an International Study Group of Pancreatic Surgery (ISGPS) definition. Surgery 142:20–25CrossRefPubMed
25.
Zurück zum Zitat Bruce J, Krukowski ZH, Al-Khairy G, Russell EM, Park KG (2001) Systematic review of the definition and measurement of anastomotic leak after gastrointestinal surgery. Br J Surg 88:1157–1168CrossRefPubMed Bruce J, Krukowski ZH, Al-Khairy G, Russell EM, Park KG (2001) Systematic review of the definition and measurement of anastomotic leak after gastrointestinal surgery. Br J Surg 88:1157–1168CrossRefPubMed
26.
Zurück zum Zitat Bassi C, Dervenis C, Butturini G, Fingerhut A, Yeo C, Izbicki J et al (2005) Postoperative pancreatic fistula: an international study group (ISGPF) definition. Surgery 138:8–13CrossRefPubMed Bassi C, Dervenis C, Butturini G, Fingerhut A, Yeo C, Izbicki J et al (2005) Postoperative pancreatic fistula: an international study group (ISGPF) definition. Surgery 138:8–13CrossRefPubMed
27.
Zurück zum Zitat Orsenigo E, Bissolati M, Socci C, Chiari D, Muffatti F, Nifosi J et al (2014) Duodenal stump fistula after gastric surgery for malignancies: a retrospective analysis of risk factors in a single centre experience. Gastric Cancer 17:733–744CrossRefPubMed Orsenigo E, Bissolati M, Socci C, Chiari D, Muffatti F, Nifosi J et al (2014) Duodenal stump fistula after gastric surgery for malignancies: a retrospective analysis of risk factors in a single centre experience. Gastric Cancer 17:733–744CrossRefPubMed
28.
Zurück zum Zitat Horan TC, Gaynes RP, Martone WJ, Jarvis WR, Emori TG (1992) CDC definitions of nosocomial surgical site infections, 1992: a modification of CDC definitions of surgical wound infections. Infect Control Hosp Epidemiol 13:606–608CrossRefPubMed Horan TC, Gaynes RP, Martone WJ, Jarvis WR, Emori TG (1992) CDC definitions of nosocomial surgical site infections, 1992: a modification of CDC definitions of surgical wound infections. Infect Control Hosp Epidemiol 13:606–608CrossRefPubMed
29.
Zurück zum Zitat Assumpcao L, Cameron JL, Wolfgang CL, Edil B, Choti MA, Herman JM et al (2008) Incidence and management of chyle leaks following pancreatic resection: a high volume single-center institutional experience. J Gastrointest Surg 12:1915–1923CrossRefPubMed Assumpcao L, Cameron JL, Wolfgang CL, Edil B, Choti MA, Herman JM et al (2008) Incidence and management of chyle leaks following pancreatic resection: a high volume single-center institutional experience. J Gastrointest Surg 12:1915–1923CrossRefPubMed
30.
31.
Zurück zum Zitat Dindo D, Demartines N, Clavien PA et al (2004) Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 240:205–213CrossRefPubMedPubMedCentral Dindo D, Demartines N, Clavien PA et al (2004) Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 240:205–213CrossRefPubMedPubMedCentral
32.
Zurück zum Zitat Kubota T et al (2014) Prognostic significance of complications after curative surgery for gastric cancer. Ann Surg Oncol 21(3):891–898CrossRefPubMed Kubota T et al (2014) Prognostic significance of complications after curative surgery for gastric cancer. Ann Surg Oncol 21(3):891–898CrossRefPubMed
33.
Zurück zum Zitat Camp RL, Dolled-Filhart M, Rimm DL (2004) X-tile: a new bioinformatics tool for biomarker assessment and outcome-based cut- point optimization. Clin Cancer Res 21:7252–7259CrossRef Camp RL, Dolled-Filhart M, Rimm DL (2004) X-tile: a new bioinformatics tool for biomarker assessment and outcome-based cut- point optimization. Clin Cancer Res 21:7252–7259CrossRef
35.
Zurück zum Zitat Sietses C, Beelen RH, Meijer S et al (1999) Immunological consequences of laparoscopic surgery, speculations on the cause and clinical implications. Langenbecks Arch Surg 384(3):250–258CrossRefPubMed Sietses C, Beelen RH, Meijer S et al (1999) Immunological consequences of laparoscopic surgery, speculations on the cause and clinical implications. Langenbecks Arch Surg 384(3):250–258CrossRefPubMed
36.
Zurück zum Zitat Bar-Yosef S, Melamed R, Page GG et al (2001) Attenuation of the tumor-promoting effect of surgery by spinal blockade in rats. Anesthesiology 94(6):1066–1073CrossRefPubMed Bar-Yosef S, Melamed R, Page GG et al (2001) Attenuation of the tumor-promoting effect of surgery by spinal blockade in rats. Anesthesiology 94(6):1066–1073CrossRefPubMed
37.
Zurück zum Zitat Beilin B, Shavit Y, Hart J et al (1996) Effects of anesthesia based on large versus small doses of fentanyl on natural killer cell cytotoxicity in the perioperative period. Anesth Analg 82(3):492–497PubMed Beilin B, Shavit Y, Hart J et al (1996) Effects of anesthesia based on large versus small doses of fentanyl on natural killer cell cytotoxicity in the perioperative period. Anesth Analg 82(3):492–497PubMed
38.
Zurück zum Zitat Beilin B, Shavit Y, Razumovsky J et al (1998) Effects of mild perioperative hypothermia on cellular immune responses. Anesthesiology 89(5):1133–1140CrossRefPubMed Beilin B, Shavit Y, Razumovsky J et al (1998) Effects of mild perioperative hypothermia on cellular immune responses. Anesthesiology 89(5):1133–1140CrossRefPubMed
39.
Zurück zum Zitat Salman H, Bergman M, Bessler H et al (2000) Hypothermia affects the phagocytic activity of rat peritoneal macrophages. Acta Physiol Scand 168(3):431–436CrossRefPubMed Salman H, Bergman M, Bessler H et al (2000) Hypothermia affects the phagocytic activity of rat peritoneal macrophages. Acta Physiol Scand 168(3):431–436CrossRefPubMed
40.
Zurück zum Zitat Page GG, Blakely WP, Ben-Eliyahu S (2001) Evidence that postoperative pain is a mediator of the tumor-promoting effects of surgery in rats. Pain 90(1–2):191–199CrossRefPubMed Page GG, Blakely WP, Ben-Eliyahu S (2001) Evidence that postoperative pain is a mediator of the tumor-promoting effects of surgery in rats. Pain 90(1–2):191–199CrossRefPubMed
41.
Zurück zum Zitat Xu YX, Ayala A, Chaudry IH (1998) Prolonged immunodepression after trauma and hemorrhagic shock. J Trauma 44(2):335–341CrossRefPubMed Xu YX, Ayala A, Chaudry IH (1998) Prolonged immunodepression after trauma and hemorrhagic shock. J Trauma 44(2):335–341CrossRefPubMed
42.
Zurück zum Zitat Klein HG (1999) Immunomodulatory aspects of transfusion: a once and future risk? Anesthesiology 91(3):861–865CrossRefPubMed Klein HG (1999) Immunomodulatory aspects of transfusion: a once and future risk? Anesthesiology 91(3):861–865CrossRefPubMed
43.
Zurück zum Zitat Cohen S, Herbert TB (1996) Health psychology: psychological factors and physical disease from the perspective of human psychoneuroimmunology. Annu Rev Psychol 47:113–142CrossRefPubMed Cohen S, Herbert TB (1996) Health psychology: psychological factors and physical disease from the perspective of human psychoneuroimmunology. Annu Rev Psychol 47:113–142CrossRefPubMed
44.
Zurück zum Zitat Moynihan JA, Ader R (1996) Psychoneuroimmunology: animal models of disease. Psychosom Med 58(6):546–558CrossRefPubMed Moynihan JA, Ader R (1996) Psychoneuroimmunology: animal models of disease. Psychosom Med 58(6):546–558CrossRefPubMed
45.
Zurück zum Zitat Ishihara Y, Matsunaga K, Iijima H et al (1999) Time-dependent effects of stressor application on metastasis of tumor cells in the lung and its regulation by an immunomodulator in mice. Psychoneuroendocrinology 24(7):713–726CrossRefPubMed Ishihara Y, Matsunaga K, Iijima H et al (1999) Time-dependent effects of stressor application on metastasis of tumor cells in the lung and its regulation by an immunomodulator in mice. Psychoneuroendocrinology 24(7):713–726CrossRefPubMed
48.
Zurück zum Zitat Goldfarb Y et al (2011) Improving postoperative immune status and resistance to cancer metastasis: a combined perioperative approach of immunostimulation and prevention of excessive surgical stress responses. Ann Surg 253(4):798–810CrossRefPubMed Goldfarb Y et al (2011) Improving postoperative immune status and resistance to cancer metastasis: a combined perioperative approach of immunostimulation and prevention of excessive surgical stress responses. Ann Surg 253(4):798–810CrossRefPubMed
49.
Zurück zum Zitat Wojtowicz-Praga S (1997) Reversal of tumor-induced immunosuppression: a new approach to cancer therapy. J Immunother 20(3):165–177CrossRefPubMed Wojtowicz-Praga S (1997) Reversal of tumor-induced immunosuppression: a new approach to cancer therapy. J Immunother 20(3):165–177CrossRefPubMed
50.
Zurück zum Zitat Chattopadhyay S, Bhattacharya S, Saha B et al (2009) Tumor-shed PGE(2) impairs IL2Rgammac-signaling to inhibit CD4 T cell survival: regulation by theaflavins. PLoS ONE 4(10):e7382CrossRefPubMedPubMedCentral Chattopadhyay S, Bhattacharya S, Saha B et al (2009) Tumor-shed PGE(2) impairs IL2Rgammac-signaling to inhibit CD4 T cell survival: regulation by theaflavins. PLoS ONE 4(10):e7382CrossRefPubMedPubMedCentral
51.
Zurück zum Zitat Saito T, Kurokawa Y, Miyazaki Y et al (2015) Which is a more reliable indicator of survival after gastric cancer surgery: postoperative complication occurrence or C-reactive protein elevation? J Surg Oncol 112:894–899CrossRefPubMed Saito T, Kurokawa Y, Miyazaki Y et al (2015) Which is a more reliable indicator of survival after gastric cancer surgery: postoperative complication occurrence or C-reactive protein elevation? J Surg Oncol 112:894–899CrossRefPubMed
Metadaten
Titel
Effect of High Postoperative Body Temperature on Long-Term Prognosis in Patients with Gastric Cancer After Radical Resection
verfasst von
Hua-Long Zheng
Jun Lu
Ping Li
Jian-Wei Xie
Jia-Bin Wang
Jian-Xian Lin
Qi-Yue Chen
Long-Long Cao
Mi Lin
Ru-Hong Tu
Ze-Ning Huang
Ju-Li Lin
Chao-Hui Zheng
Chang-Ming Huang
Publikationsdatum
27.02.2019
Verlag
Springer International Publishing
Erschienen in
World Journal of Surgery / Ausgabe 7/2019
Print ISSN: 0364-2313
Elektronische ISSN: 1432-2323
DOI
https://doi.org/10.1007/s00268-019-04965-5

Weitere Artikel der Ausgabe 7/2019

World Journal of Surgery 7/2019 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.